Daniele De Mari
CEO

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.
Funding not disclosed
